Adjuvant strategies to tackle mcr-mediated polymyxin resistance

Madison R Nuske1,2, Junlang Zhong1,2, Renjie Huang3

  • 1School of Chemistry, The University of Melbourne Parkville Victoria 3010 Australia ivanhoe.leung@unimelb.edu.au.

RSC Medicinal Chemistry
|November 14, 2024
PubMed

Insights

Mobile colistin resistance (mcr) genes on plasmids threaten antibiotic use. This review explores polymyxin adjuvants and MCR inhibitors to combat resistance and restore antibiotic effectiveness.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Pharmacology

Background:

  • Mobile colistin resistance (mcr) genes are a growing global health threat, facilitating antibiotic resistance spread via plasmids.
  • MCR enzymes modify lipopolysaccharides (LPS), preventing polymyxin binding and conferring resistance to these critical last-resort antibiotics.

Purpose of the Study:

  • To review recent advancements in developing polymyxin adjuvants to overcome mcr-mediated resistance.
  • To focus on strategies including MCR inhibitors and alternative approaches to restore polymyxin efficacy.

Main Methods:

  • Literature review of recent research on mcr genes, polymyxin resistance mechanisms, and adjuvant development.
  • Analysis of studies focusing on MCR inhibitors and other resistance modulation strategies.

Main Results:

  • Polymyxin adjuvants show promise in restoring sensitivity to polymyxins in resistant bacteria.
  • MCR inhibitors and alternative approaches are being actively investigated to combat resistance.

Conclusions:

  • Developing polymyxin adjuvants is a crucial strategy to extend the utility of last-resort antibiotics.
  • Continued research into MCR inhibitors and novel resistance modulation techniques is essential for addressing the antibiotic resistance crisis.

Related Concept Videos

Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
3.7K
Antibiotic Selection00:57

Antibiotic Selection

Overview
52.3K
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
3
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Cholinergic Antagonists: Pharmacokinetics01:24

Cholinergic Antagonists: Pharmacokinetics

Cholinergic antagonists—such as antimuscarinics—are available in oral, topical, ocular, parenteral, and inhalational formulations. Most antimuscarinics are oral formulations,  while scopolamine is available as a topical patch, and ipratropium and tiotropium are available as inhalation aerosols or powders. Atropine, tropicamide, and cyclopentolate are topically instilled in the eye. Most antimuscarinics are lipid-soluble and readily absorbed from the gastrointestinal tract and...
411